Abstract
Cell transplantation is a novel therapy for patients with postinfarction ven tricular dysfunction and congestive heart failure. The potential of mesenchy mal stem cells (MSCs) to be used in the injured myocardium is unlimited because of their ability to self-renew and differentiate into cardiomyocytes in vitro and in vivo. In addition, MSCs are easy to harvest and have a high prolif eration capability. Finally, autologous MSCs can survive permanently and in tegrate with healthy host tissue to form new myocardium after implantation in vivo. We have used autologous cultured MSCs grafts for mouse and rat myo cardial infarction in more than 500 cases. From these grafting experiments, it has been shown that cultured autologous MSCs grafting is a useful approach in the treatment of ischemic heart failure. This chapter offers a step-by-step guide for successful research on cultured MSCs for the treatment of myocardial inf arction, as well as a set of techniques for evaluating postimplantation myocar dial repair.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Krause, D. S. (2002) Plasticity of marrow-derived stem cells. Gene Ther. 9, 754–758.
Makino, S., Fukuda, K., Miyoshi, S. et al. (1999) Cardiomyocytes can be gener ated from marrow stromal cells in vitro. J. Clin. Invest. 103, 697–705.
Toma, C., Pittenger, M. F., Cahill, K. S., et al. (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circu lation 105, 93–98.
Wang, J. S., Shum-Tim, D., Galipeau, J., et al. (2000) Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J. Thorac. Cardiovasc. Surg. 120, 999–1005.
Tomita, S., Li, R. K., Weisel, R. D., et al. (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100, II247–II256.
Shake, J. G., Gruber, P. J., Baumgartner, W. A., et al. (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73, 1919–1925.
Dorfman, J., Duong, M., Zibaitis, A., et al. (1998) Myocardial tissue engineering with autologous myoblast implantation. J. Thorac. Cardiovasc. Surg 116, 744–751.
Kim, E. J., Li, R. K., Weisel, R. D., et al. (2001) Angiogenesis by endothelial cell transplantation. J. Thorac. Cardiovasc. Surg. 122, 963–971.
Wang, J. S., Shum-Tim, D., Chedrawy, E., and Chiu, R. C. (2001) The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J. Thorac. Cardiovasc. Surg. 122, 699–705.
Kessler, P. D. and Byrne, B. J. (1999) Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu. Rev. Physiol. 61, 219–242.
Suzuki, K., Brand, N.J., Smolenski, R. T., et al. (2000) Development of a novel method for cell transplantation through the coronary artery. Circulation 102, III359–III364.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Tang, Y.L. (2005). Autologous Mesenchymal Stem Cells for Post-Ischemic Myocardial Repair. In: Sun, Z. (eds) Molecular Cardiology. Methods in Molecular Medicine™, vol 112. Humana Press. https://doi.org/10.1385/1-59259-879-X:183
Download citation
DOI: https://doi.org/10.1385/1-59259-879-X:183
Publisher Name: Humana Press
Print ISBN: 978-1-58829-363-3
Online ISBN: 978-1-59259-879-3
eBook Packages: Springer Protocols